A revolutionary brain implant allows a paralyzed individual to communicate through synthesized speech and singing by capturing neural signals from the speech region of their brain, using AI to decode and reproduce their voice and vocal inflections in real time.
Innovative AI software revolutionizes healthcare access in Brazil's Amazon, quadrupling pharmacists' capacity to process prescriptions while safeguarding against dangerous errors, signaling a potential global solution for overstretched medical systems.
University Hospitals adopts cutting-edge AI-powered Varian Ethos 2.0 system for precision adaptive radiotherapy, enabling personalized cancer treatment plans and higher radiation doses while minimizing harm to healthy tissue through real-time imaging and motion tracking.
A wall-mounted AI device that scans feet for fluid buildup can predict heart failure hospitalizations an average of 13 days in advance, potentially allowing timely interventions to prevent hospitalization, according to research presented at the British Cardiovascular Society conference.
Paradromics, a neurotech startup rivaling Elon Musk's Neuralink, successfully implanted and removed its brain-computer interface device during human surgery, marking a major milestone as it prepares for broader clinical trials to help people with severe motor impairments like paralysis.
The FDA's new AI tool for reviewing medical devices, CDRH-GPT, is struggling with basic tasks like uploading documents and accessing recent studies, raising concerns about rushing AI adoption before it's ready to handle complex regulatory work accurately and safely.
Neurotech startup Paradromics has achieved a major milestone by successfully implanting its brain-computer interface in a human for the first time, paving the way for a clinical trial later this year to study the long-term safety and use of its technology.
In a groundbreaking medical milestone, Paradromics, a brain-computer interface startup, successfully implanted and safely removed its brain implant, Connexus, from a human patient for the first time, paving the way for restoring speech and communication for those with paralysis.
Early AI investor Elad Gil is now betting big on using AI to transform traditional businesses through roll-ups, acquiring mature companies and using AI to radically increase their margins, then repeating the process to create tech-enabled giants in industries like legal services.
A new AI test can identify which men with high-risk prostate cancer will benefit most from the life-extending drug abiraterone, potentially saving lives and NHS costs by avoiding unnecessary treatment for those unlikely to benefit.